DAVID
BERNARDO ORDIZ
PROFESORA SUSTITUTA/PROFESOR SUSTITUTO
![Foto de DAVID](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (27)
2024
-
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Scientific reports, Vol. 14, Núm. 1, pp. 3000
-
Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment
Frontiers in Immunology, Vol. 15
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
2022
-
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge
International Journal of Molecular Sciences, Vol. 23, Núm. 19
-
Metabolomics study of COVID-19 patients in four different clinical stages
Scientific reports, Vol. 12, Núm. 1, pp. 1650
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can
Frontiers in Immunology, Vol. 12
-
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies
Scientific Reports, Vol. 11, Núm. 1
-
Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
Growth arrest-specific factor 6 (Gas6) is increased in covid-19 patients and predicts clinical outcome
Biomedicines, Vol. 9, Núm. 4
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
European Journal of Immunology, Vol. 51, Núm. 12, pp. 2708-3145
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Vol. 27, Núm. 2, pp. 268-274
2020
-
A quick flow cytometry protocol to assess Helicobacter pylori viability
Journal of Microbiological Methods, Vol. 177
-
Serum adipokines as non-invasive biomarkers in Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596